These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 24085810

  • 21. Management of hepatocellular carcinoma.
    Del Pozo AC, López P.
    Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209
    [Abstract] [Full Text] [Related]

  • 22. Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.
    Cui HZ, Dai GH, Shi Y, Chen L.
    Hepatogastroenterology; 2013 May; 60(122):305-10. PubMed ID: 23574656
    [Abstract] [Full Text] [Related]

  • 23. Hepatocellular carcinoma: current questions and future directions.
    Gish RG.
    Clin Adv Hematol Oncol; 2015 Mar; 13(3):176-9. PubMed ID: 26352425
    [No Abstract] [Full Text] [Related]

  • 24. Hepatocellular carcinoma: status in the era of liver transplantation.
    Singhal A, Jabbour N.
    J Okla State Med Assoc; 2009 Dec; 102(12):355-61. PubMed ID: 20131731
    [No Abstract] [Full Text] [Related]

  • 25. Review article: the management of hepatocellular carcinoma.
    Cabrera R, Nelson DR.
    Aliment Pharmacol Ther; 2010 Feb 15; 31(4):461-76. PubMed ID: 19925500
    [Abstract] [Full Text] [Related]

  • 26. Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: a propensity score matching study.
    Bai W, Wang YJ, Zhao Y, Qi XS, Yin ZX, He CY, Li RJ, Wu KC, Xia JL, Fan DM, Han GH.
    J Dig Dis; 2013 Apr 15; 14(4):181-90. PubMed ID: 23324079
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Current approach to hepatocellular carcinoma.
    Abrams P, Marsh JW.
    Surg Clin North Am; 2010 Aug 15; 90(4):803-16. PubMed ID: 20637949
    [Abstract] [Full Text] [Related]

  • 30. Multimodality treatment involving radiotherapy for advanced liver-confined hepatocellular carcinoma.
    Yoon HI, Seong J.
    Oncology; 2014 Aug 15; 87 Suppl 1():90-8. PubMed ID: 25427739
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?
    Jiang W, Zeng ZC.
    Oncology; 2013 Aug 15; 84 Suppl 1():69-74. PubMed ID: 23428862
    [Abstract] [Full Text] [Related]

  • 34. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
    Yang JD, Harmsen WS, Slettedahl SW, Chaiteerakij R, Enders FT, Therneau TM, Orsini L, Kim WR, Roberts LR.
    Clin Gastroenterol Hepatol; 2011 Jul 15; 9(7):617-23.e1. PubMed ID: 21459158
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Contemporary management of hepatocellular carcinoma.
    Palmer D.
    Clin Med (Lond); 2008 Aug 15; 8(4):442-7. PubMed ID: 18724617
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Hepatocellular carcinoma.
    Daoudaki M, Fouzas I.
    Wien Med Wochenschr; 2014 Nov 15; 164(21-22):450-5. PubMed ID: 25182146
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.